As2O3 synergistically reactivate latent HIV-1 by induction of NF-κB

Antiviral Research

Volumn 100, Issue 3, 2013, Pages 688-697

  Wang, Pengfei ^a   Qu, Xiying ^a   Wang, Xiaohui ^a   Liu, Lin ^a   Zhu, Xiaoli ^a   Zeng, Hanxian ^a   Zhu, Huanzhang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

As2O3; HIV 1 latency; NF B; Synergistic reactivation

Indexed keywords

ARSENIC TRIOXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROSTRATIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACETYLSALICYLIC ACID; ORGANOARSENIC DERIVATIVE; OXIDE; PHORBOL ESTER; VALPROIC ACID;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN IMMUNODEFICIENCY VIRUS 1; LATENT PERIOD; LEUKEMIA CELL LINE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; VIRUS INDUCTION; VIRUS REACTIVATION; VIRUS REPLICATION; CELL CULTURE; CELL STRAIN HEK293; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; LONG TERMINAL REPEAT; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY; REPORTER GENE; SIGNAL TRANSDUCTION; VIRUS ACTIVATION; VIRUS LATENCY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ARSENICALS; ASPIRIN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, REPORTER; HEK293 CELLS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; JURKAT CELLS; LEUKOCYTES, MONONUCLEAR; MICROSCOPY, FLUORESCENCE; NF-KAPPA B; OXIDES; PHORBOL ESTERS; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VALPROIC ACID; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84887283365     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.10.010     Document Type: Article

References (74)

1. + T cells AIDS 22 2008 1131 1135
2. A. Barchowsky, R.R. Roussel, L.R. Klei, P.E. James, N. Ganju, K.R. Smith, and E.J. Dudek Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways Toxicol. Appl. Pharmacol. 159 1999 65 75 (Pubitemid 29404762)
3. 3 enhances retroviral reverse transcription and counteracts Ref1 antiviral activity J. Virol. 77 2003 3167 3180 (Pubitemid 36228101)
4. A. Biancotto, J. Grivel, F. Gondois-Rey, L. Bettendroffer, R. Vigne, S. Brown, L.B. Margolis, and I. Hirsch Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue J. Virol. 78 2004 10507 10515 (Pubitemid 39258376)
5. G.D. Bren, J. Whitman, N. Cummins, B. Shepard, S.A. Rizza, S.A. Trushin, and A.D. Badley Infected cell killing by HIV-1 protease promotes NF-κB dependent HIV-1 replication PloS One 3 2008 e2112
6. T.R. Brummelkamp, S.M. Nijman, A.M. Dirac, and R.A. Bernards Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB Nature 424 2003 797 801 (Pubitemid 37021711)
7. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins Blood 88 1996 1052 1061 (Pubitemid 26333331)
8. X. Contreras, M. Barboric, T. Lenasi, and B.M. Peterlin HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription PLoS Pathog. 3 2007 e146
9. X. Contreras, M. Schweneker, C. Chen, J.M. McCune, S.G. Deeks, J. Martin, and B.M. Peterlin Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells J. Biol. Chem. 284 2009 6782 6789
10. R. Davis, D.H. Peters, and D. McTavish Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy Drugs 47 1994 332 372
11. M. Delhase, M. Hayakawa, Y. Chen, and M. Karin Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation Science 284 1999 309 313
12. D. Ding, X. Qu, L. Li, X. Zhou, S. Liu, S. Lin, P. Wang, S. Liu, C. Kong, X. Wang, L. Liu, and H. Zhu Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation Virology 440 2013 182 189
13. E.J. Duh, W.J. Maury, T.M. Folks, A.S. Fauci, and A.B. Rabson Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat Proc. Natl. Acad. Sci. U.S.A. 86 1989 5974 5978 (Pubitemid 19217570)
14. K. Felix, S.K. Manna, K. Wise, J. Barr, and G.T. Ramesh Low levels of arsenite activates nuclear factor-kappaB and activator protein-1 in immortalized mesencephalic cells J. Biochem. Mol. Toxicol. 19 2005 67 77 (Pubitemid 40571687)
15. P. Fenaux Inhibitors of DNA methylation: beyond myelodysplastic syndromes Nat. Clin. Pract. Oncol. 2 2005 S36 S44
16. J.B. Fitzgerald, B. Schoeberl, U.B. Nielsen, and P.K. Sorger Systems biology and combination therapy in the quest for clinical efficacy Nat. Chem. Biol. 2 2006 458 466 (Pubitemid 44266307)
17. T.M. Folks, K.A. Clouse, J. Justement, A. Rabson, E. Duh, J.H. Kehrl, and A.S. Fauci Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone Proc. Natl. Acad. Sci. U.S.A. 86 1989 2365 2368 (Pubitemid 19102509)
18. R. Gaynor Cellular transcription factors involved in the regulation of HIV-1 gene expression AIDS 6 1992 347 364
19. S. Ghosh, and M. Karin Missing pieces in the NF-kappaB puzzle Cell 109 Suppl. 2002 S81 S96
20. L. Gila, N. Elena, S. Yechezkel, and B. Mary P53-associated 3′ → 5′ exonuclease activity in nuclear and cytoplasmic compartments of cells Oncogene 22 2003 233 245 (Pubitemid 36174180)
21. G.E. Griffin, K. Leung, T.M. Folks, S. Kunkel, and G.J. Nabel Activation of HIV gene expression during monocyte differentiation by induction of NF-κB Nature 339 1989 70 73 (Pubitemid 19115896)
22. Y. Hu, X. Jin, and E.T. Snow Effect of arsenic on transcription factor AP-1 and NF-kappaB DNA binding activity and related gene expression Toxicol. Lett. 133 2002 33 45 (Pubitemid 34657266)
23. J. Huang, F. Wang, E. Argyris, K. Chen, Z. Liang, H. Tian, W. Huang, K. Squires, G. Verlinghieri, and H. Zhang Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes Nat. Med. 13 2007 1241 1247 (Pubitemid 47530631)
24. K. Imai, H. Togami, and T. Okamoto Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294 J. Biol. Chem. 285 2010 16538 16545
25. I. Isobe, M. Michikawa, and K. Yanagisawa Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid β-protein and chloroquine in cultured rat astrocytes Neurosci. Lett. 266 1999 129 132 (Pubitemid 29227341)
26. A. Jordan, D. Bisgrove, and E. Verdin HIV reproducibly establishes a latent infection after acute infection of T cells in vitro EMBO J. 22 2003 1868 1877 (Pubitemid 36460143)
27. M. Karin, and Y. Ben-Neriah Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity Annu. Rev. Immunol. 18 2000 621 663 (Pubitemid 30365393)
28. M. Karin, and M. Delhase The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling Semin. Immunol. 12 2000 85 98 (Pubitemid 30114019)
29. J. Karn The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit Curr. Opin. HIV AIDS 6 2011 4 11
30. S. Kinoshita, L. Su, M. Amano, L.A. Timmerman, H. Kaneshima, and G.P. Nolan The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells Immunity 6 1997 235 244 (Pubitemid 27148590)
31. O. Kutuk, and H. Basaga Aspirin inhibits TNFα- and IL-1-induced NF-κB activation and sensitizes HeLa cells to apoptosis Cytokine 25 2004 229 237 (Pubitemid 38229414)
32. K.G. Lassen, K.X. Ramyar, J.R. Bailey, Y. Zhou, and R.F. Siliciano Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells PLoS Pathog. 2 2006 e68
33. G. Lehrman, I.B. Hogue, S. Palmer, C. Jennings, C.A. Spina, A. Wiegand, A.L. Landay, R.W. Coombs, D.D. Richman, and J.W. Mellors Depletion of latent HIV-1 infection in vivo: a proof-of-concept study The Lancet 366 2005 549 555 (Pubitemid 41140329)
34. Z. Li, J. Guo, Y. Wu, and Q. Zhou The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation Nucleic Acids Res. 41 2013 277 287
35. M. Lusic, B. Marini, H. Ali, B. Lucic, R. Luzzati, and M. Giacca Proximity to PML nuclear bodies regulates HIV-1 latency in CD4+ T cells Cell Host Microbe 13 2013 665 677
36. M.D. Marsden, and J.A. Zack Eradication of HIV: current challenges and new directions J. Antimicrob. Chemother. 63 2009 7 10
37. U. Mbonye, and J. Karn Control of HIV latency by epigenetic and non-epigenetic mechanisms Curr. HIV Res. 9 2011 554 567
38. R. Mehla, S. Bivalkar-Mehla, R. Zhang, I. Handy, H. Albrecht, S. Giri, P. Nagarkatti, M. Nagarkatti, and A. Chauhan Bryostatin modulates latent HIV-1 infection via PKC and AMPK signaling but inhibits acute infection in a receptor independent manner PLoS One 5 2010 e11160
39. W.J. Miller, H.M. Schipper, J.S. Lee, J. Singer, and S. Waxman Mechanisms of action of arsenic trioxide Cancer Res. 62 2002 3893 3903 (Pubitemid 34792653)
40. G. Nabel, and D. Baltimore An inducible transcription factor activates expression of human immunodeficiency virus in T cells Nature 326 1987 711 713 (Pubitemid 17059793)
41. R. Nathans, C. Chu, A.K. Serquina, C. Lu, H. Cao, and T.M. Rana Cellular microRNA and P bodies modulate host-HIV-1 interactions Mol. Cell 34 2009 696 709
42. M.J. Pace, L. Agosto, E.H. Graf, and U. O'Doherty HIV reservoirs and latency models Virology 411 2011 344 354
43. J.W. Pierce, R. Schoenleber, G. Jesmok, J. Best, S.A. Moore, T. Collins, and M.E. Gerritsen Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo J. Biol. Chem. 272 1997 21096 21103 (Pubitemid 27373968)
44. M. Pion, R. Stalder, R. Correa, B. Mangeat, G.J. Towers, and V. Piguet Identification of an arsenic-sensitive block to primate lentiviral infection of human dendritic cells J. Virol. 81 2007 12086 12090 (Pubitemid 47623841)
45. J.M. Prins, S. Jurriaans, R.M. van Praag, H. Blaak, R. van Rij, P.T.A. Schellekens, I.J. Ten Berge, S. Yong, C.H. Fox, and M.T. Roos Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy AIDS 13 1999 2405 2410
46. X. Qu, J. Du, C. Zhang, W. Fu, H. Xi, J. Zou, and J. Hou Arsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6 PLoS One 7 2012 e32215
47. A.L. Remoli, G. Marsili, A. Battistini, and M. Sgarbanti The development of immune-modulating compounds to disrupt HIV latency Cytokine Growth Factor Rev. 23 2012 159 172
48. S. Reuse, M. Calao, K. Kabeya, A. Guiguen, J. Gatot, V. Quivy, C. Vanhulle, A. Lamine, D. Vaira, and D. Demonte Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection PLoS One 4 2009 e6093
49. D.D. Richman, D.M. Margolis, M. Delaney, W.C. Greene, D. Hazuda, and R.J. Pomerantz The challenge of finding a cure for HIV infection Science 323 2009 1304 1307
50. R.R. Roussel, and A. Barchowsky Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation Arch. Biochem. Biophys. 377 2000 204 212 (Pubitemid 30257306)
51. N. Sagot-Lerolle, A. Lamine, M. Chaix, F. Boufassa, J. Aboulker, D. Costagliola, C. Goujard, C. Paller, J. Delfraissy, and O. Lambotte Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir AIDS 22 2008 1125 1129
52. S. Sebastian, E. Sokolskaja, and J. Luban Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent manner J. Virol. 80 2006 2051 2054 (Pubitemid 43228745)
53. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients Blood 89 1997 3354 3360
54. J.A. Shumilla, K.E. Wetterhahn, and A. Barchowsky Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism Arch. Biochem. Biophys. 349 1998 356 362 (Pubitemid 28368681)
55. J.D. Siliciano, J. Lai, M. Callender, E. Pitt, H. Zhang, J.B. Margolick, J.E. Gallant, J. Cofrancesco, R.D. Moore, and S.J. Gange Stability of the latent reservoir for HIV-1 in patients receiving valproic acid J. Infect. Dis. 195 2007 833 836 (Pubitemid 46363928)
56. S.L. Soignet, P. Maslak, Z. Wang, S. Jhanwar, E. Calleja, L.J. Dardashti, D. Corso, A. DeBlasio, J. Gabrilove, and D.A. Scheinberg Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide N. Engl. J. Med. 339 1998 1341 1348 (Pubitemid 28509343)
57. R. Stalder, F. Blanchet, B. Mangeat, and V. Piguet Arsenic modulates APOBEC3G-mediated restriction to HIV-1 infection in myeloid dendritic cells J. Leukocyte Biol. 88 2010 1251 1258
58. D. Sumi, Y. Shinkai, and Y. Kumagai Signal transduction pathways and transcription factors triggered by arsenic trioxide in leukemia cells Toxicol. Appl. Pharm. 244 2010 385 392
59. X. Tan, L. Hu, L.J. Luquette III, G. Gao, Y. Liu, H. Qu, R. Xi, Z.J. Lu, P.J. Park, and S.J. Elledge Systematic identification of synergistic drug pairs targeting HIV Nat. Biotechnol. 30 2012 1125 1130
60. H. Tominaga, M. Ishiyama, F. Ohseto, K. Sasamoto, T. Hamamoto, K. Suzuki, and M. Watanabe A water-soluble tetrazolium salt useful for colorimetric cell viability assay Anal. Commun. 36 1999 47 50
61. M. Tyagi, and M. Bukrinsky HIV latency: the major hurdle in HIV eradication Mol. Med. 18 2012 1096 1108
62. A.F.B. Victoriano, and T. Okamoto Transcriptional control of HIV replication by multiple modulators and their implication for a novel antiviral therapy AIDS Res. Hum. Retrov. 28 2012 125 138
63. J. Vlach, and P.M. Pitha Hexamethylene bisacetamide activates the human immunodeficiency virus type 1 provirus by an NF-κB-independent mechanism J. Gen. Virol. 74 1993 2401 2408 (Pubitemid 23332301)
64. F. Wang, Y. Xu, J. Sullivan, E. Souder, E.G. Argyris, E.A. Acheampong, J. Fisher, M. Sierra, M.M. Thomson, and R. Najera IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART J. Clin. Invest. 115 2005 128 137 (Pubitemid 40385513)
65. S.A. Williams, L. Chen, H. Kwon, D. Fenard, D. Bisgrove, E. Verdin, and W.C. Greene Prostratin antagonizes HIV latency by activating NF-κB J. Biol. Chem. 279 2004 42008 42017 (Pubitemid 39313652)
66. F. Wolschendorf, A. Duverger, J. Jones, F.H. Wagner, J. Huff, W.H. Benjamin, M.S. Saag, M. Niederweis, and O. Kutsch Hit-and-run stimulation: a novel concept to reactivate latent HIV-1 infection without cytokine gene induction J. Virol. 84 2010 8712 8720
67. S. Xing, S. Bhat, N.S. Shroff, H. Zhang, J.A. Lopez, J.B. Margolick, J.O. Liu, and R.F. Siliciano Novel structurally related compounds reactivate latent HIV-1 in a bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation J. Antimicrob. Chemother. 67 2012 398 403
68. S. Xing, C.K. Bullen, N.S. Shroff, L. Shan, H. Yang, J.L. Manucci, S. Bhat, H. Zhang, J.B. Margolick, and T.C. Quinn Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation J. Virol. 85 2011 6060 6064
69. S. Xing, and R.F. Siliciano Targeting HIV latency: pharmacologic strategies toward eradication Drug Discov. Today 00 2012 1 11
70. H. Yang, S. Xing, L. Shan, K. O Connell, J. Dinoso, A. Shen, Y. Zhou, C.K. Shrum, Y. Han, and J.O. Liu Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation J. Clin. Invest. 119 2009 3473 3486
71. H. Ying, Y. Zhang, X. Zhou, X. Qu, P. Wang, S. Liu, D. Lu, and H. Zhu Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB PloS One 7 2012 e48832
72. L. Ylisastigui, N.M. Archin, G. Lehrman, R.J. Bosch, and D.M. Margolis Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression AIDS 18 2004 1101 1108 (Pubitemid 38738509)
73. Q. Zhou, and J.H. Yik The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation Microbiol. Mol. Biol. Rev. 70 2006 646 659 (Pubitemid 44484688)
74. G. Zhu, J. Cai, J. Zhang, Y. Zhao, and B. Xu Abnormal nuclear factor (NF)-κB signal pathway and aspirin inhibits tumor necrosis factor α- induced NF-κB activation in Keloid fibroblasts Dermatol. Surg. 33 2007 697 708 (Pubitemid 46855048)